Antihistamine Mechanism and Clinical Applications

Primary Mechanism of Action

• Antihistamines block histamine's effects on target tissues, reducing allergic symptoms such as pruritus, flushing, and urticaria, by competitively antagonizing histamine receptors, particularly H1 receptors, which are present on nerve endings, smooth muscles, and glandular cells 1, 2

Types of Histamine Receptors Affected

• There are four known histamine receptors (H1, H2, H3, and H4) located throughout the body, but H1 receptors are the most clinically relevant for allergic responses, and most antihistamines used for allergic conditions primarily target H1 receptors 1
• H2 receptors are mostly found within the gastrointestinal tract with limited distribution in vascular smooth muscle cells and play a minor role in allergic pathophysiology 1

Clinical Effects Based on Receptor Blockade

• H1 receptor blockade effectively treats cutaneous symptoms including pruritus, flushing, and urticaria, and antihistamines begin working within 30 minutes, but peak plasma concentrations aren't reached until 60-120 minutes, with maximal tissue effects taking an additional 60-90 minutes 2
• Antihistamines are less effective at treating cardiovascular and respiratory symptoms such as hypotension or bronchospasm when used acutely 2

Differences Between First and Second Generation Antihistamines

• The primary difference between first and second-generation antihistamines is central nervous system penetration, which explains the greater sedation with first-generation agents, according to the American Academy of Allergy, Asthma, and Immunology 3

Important Clinical Considerations

• When treating anaphylaxis, antihistamines should never be used as first-line treatment in place of epinephrine, as they cannot reverse the life-threatening cardiovascular and respiratory effects of severe allergic reactions, as recommended by the American College of Allergy, Asthma, and Immunology 4, 1

Use of H2 Receptor Blockers in Allergic Reactions

Rationale for Combined H1/H2 Blockade

• Adding an H2 receptor blocker to an H1 antihistamine provides superior control of allergic symptoms—especially cutaneous manifestations such as urticaria—by inhibiting histamine action at both receptor types, which act synergistically during allergic reactions. 5

Guideline Recommendations (NIAID)

• The NIAID expert panel notes that evidence supporting routine H2 antihistamine use in emergency anaphylaxis is minimal; therefore, H2 blockers may be used adjunctively for symptom relief but are not required by current guidelines. 6
• H2 blockers are recommended only as third‑line adjunctive therapy and must never replace epinephrine, which remains the sole first‑line treatment for anaphylaxis. 7

Limitations and Contraindications

• H2 blockers do not reverse upper‑airway obstruction such as stridor, laryngeal edema, or bronchospasm in anaphylactic patients. 6
• H2 blockers do not correct hypotension or shock associated with severe allergic reactions. 7

Evidence Quality

• The overall evidence base for the use of H2 blockers in anaphylaxis is limited and of low quality, with most data supporting benefit only for cutaneous symptom improvement in acute allergic syndromes rather than life‑threatening manifestations. 5